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Functional gastrointestinal disorders (FGD), namely, func-
tional gastrointestinal disorders (FGID) and irritable bowel
syndrome (IBS), are always in the focus of gastroenterol-
ogists, because of their polymorphic symptomatology and
insufficiently defined causes and habits that influence the
appearance of FGD. Irritable bowel syndrome (IBS) is a
functional gastrointestinal disorder (FGID) characterized by
abdominal pain or discomfort and alteration of bowel habits
in the absence of an organic disorder. IBS is themost common
gastrointestinal disorder and the prevalence varies from 4%
to 22% in the population based studies [1–3]. Functional
dyspepsia (FD) is common and significantly impairs quality
of life. Symptoms of FD are considered to originate from
the gastroduodenal region, classified by the Rome criteria as
disorders of brain-gut interaction without structural alter-
ation. However, it is now apparent that FD is a number
of syndromes, the epigastric pain syndrome (bothersome
epigastric pain or epigastric burning) and the postprandial
distress syndrome (with bothersome postprandial fullness or
early satiation) and there are wide-ranging symptoms and
severity [4].
Papers in this special issue additionally illustrate the
approach to FGD from various points of view. W.-P. Meng
and coworkers presented a review article that describes the
mutual effects of H. pylori and hormones in functional
dyspepsia and provided new insight into the pathogenesis
of functional dyspepsia. H. pylori strains have been shown
to affect the secretion of several hormones, including 5-HT,
ghrelin, dopamine, and gastrin, and altered levels of these
hormones might be the cause of the psychological disorders
of functional dyspepsia patients.
P. Enck and his team of investigators revealed that
somatic comorbid condition and/or regular medication were
significantly older than those with functional constipation
and had lower health and social status, but similar general life
satisfaction. Their quality-of-life was lower for the physical
but not for the mental health domain, while among those
with functional constipation, the mental health domain
distinguished IBS-Constipation dominant type individuals
from those with functional constipation but without pain.
C.-H. Yi and associates reported rectal decompression
with either rectal or sham tube improved distension-induced
abdominal symptoms. Their study indicates that the mecha-
nisms that improved abdominal symptoms by rectal decom-
pression might be mediated by a central pathway instead of a
peripheral mechanism.
A well-designed study by W. Tao et al. identified a set of
35 differentially expressed miRNAs that bear the potential to
be molecular markers of T2DM with D-IBS, as they clearly
discriminated T2DM with D-IBS from healthy subjects.
Furthermore, our findings identified three miRNA species,
hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b, which are
differentially expressed in the peripheral circulation of
patients suffering from T2DM with D-IBS and are among
the miRNAs that are implicated in the MAKP signaling
pathway.
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Study of Chinese cohort with FD, provided by Chen et
al., demonstrated that sleep quality and marriage status and
introversion-extroversion of personality traits significantly
influenced the conventional treatment effects on Chinese FD
patients.
S. Jizhong and his colleagues outlined that IBS patients
during stress released corticotrophin release factor which
leads to the damage of the intestinal mucosa barrier. TLR2
and TLR4 activation produces an inflammatory reaction,
which can concurrently affect the digestive tract and the
CNS and induces the corresponding digestive and psychiatric
symptoms.
All the investigations represent a contribution to clarify
the pathogenesis of FGD, but, judging from the results
presented, functional gastrointestinal disorder will attract
the intention of investigators for a longer period, because
the definitive solution about the pathogenesis of FGD and,
consecutively, the definitive guidelines for the therapy remain
yet to be elucidated.
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